• 구독신청
  • My스크랩
  • 지면신문
FNTIMES 대한민국 최고 금융 경제지
ad

Kumho Petrochemical's Buyback Dilemma: Cheap Stock, Cautious Returns

곽호룡 기자

horr@fntimes.com

기사입력 : 2026-09-02 08:12

Revised Commercial Act Limits Treasury Share Use
Company Likely to Clarify Shareholder Return Stance at Next Year's AGM
Possibility of Renewed 'Nephew's Revolt' Cannot Be Ruled Out

AI generated

AI generated

이미지 확대보기
[Korea Financial Times, Gwak Horyung] Kumho Petrochemical strengthened shareholder returns amid a management rights dispute, but has turned cautious about further returns now that the dispute has entered a lull. With the stock still trading at a price-to-book ratio (PBR) of around 0.45x, how the company handles its remaining treasury shares under a new shareholder return policy next year is set to be tested once again.

Kumho Petrochemical began focusing on enhancing shareholder value in 2021. At the time, Park Chul-wan, then a managing director and the largest individual shareholder, who is also a nephew of Chairman Park Chan-koo, challenged for management control under the banner of "expanded dividends."

In response, Kumho Petrochemical announced a shareholder return policy under which it would, in addition to its existing dividend policy (20-25% of standalone net income), carry out annual treasury share buybacks and cancellations (10-15% of standalone net income).

Rather than simply expanding dividends, the company succeeded in persuading shareholders with a plan to grow future corporate value by pursuing a shift toward high-profitability businesses alongside predictable shareholder returns.

At Kumho Petrochemical, neither side of the dispute can secure management control with its stake alone. As of the end of June this year, the Park Chan-koo side held 18% and the Park Chul-wan side held 12%, a gap of only six percentage points. This structure makes the support of general shareholders essential.

In 2024, the company announced a new shareholder return policy that added a plan to cancel 50% of its existing treasury shares in stages. Kumho Petrochemical had acquired a large volume of treasury shares during its 2001 merger with Kumho Chemical. Just before the first cancellation, the treasury shares it held accounted for 18% of total shares outstanding. The company is currently carrying out a plan to cancel half of that amount by this year.

Despite these active shareholder return efforts, the stock has continued to languish. As of the end of the second quarter this year, its PBR stood at just 0.45x, down from 0.65x in 2022-2023. To be sure, petrochemical companies tend to have relatively low PBRs given their large capital base from heavy equipment investment and the earnings volatility inherent to a cyclical industry. Even accounting for this, however, some point out that the current share price is excessively undervalued.

The core reason behind the PBR undervaluation is the slowdown in the petrochemical industry. The company's net income has continued to decline, falling from KRW 1.0257 trillion in 2022 to KRW 447 billion in 2023, KRW 348.6 billion in 2024, and KRW 290.9 billion in 2025. Meanwhile, total equity has kept growing, from KRW 5.6534 trillion in 2022 to KRW 6.2465 trillion in 2025, adding to the capital burden and driving a sharp decline in return on equity (ROE).

To improve capital efficiency, a company must either increase profit or reduce capital. If the petrochemical industry downturn is unlikely to improve significantly in the short term, additional cancellation of treasury shares—a relatively straightforward option—could be called for.

Notably, Kumho Petrochemical still holds the remaining 50% of its treasury shares, for which no clear use has been identified. In its 2024 shareholder return plan, the company stated these shares were "a resource for future growth, including future business restructuring, joint venture (JV) establishment, and friendly-stake exchanges (M&A)." So far, however, no large-scale transaction for such purposes has materialized. In addition, the revised Commercial Act, which took effect this year, has placed new restrictions on the use of treasury shares. Under the revised law, existing treasury shares must in principle be cancelled, and holding or disposing of them for exceptional purposes, such as management needs, now requires shareholder approval at a general meeting.

As a result, Kumho Petrochemical is expected to clarify its stance on its remaining treasury shares through a new shareholder return policy next year.

In the process, the so-called "nephew's revolt" could flare up again. Former Managing Director Park has not submitted a shareholder proposal for two consecutive years, in 2025 and this year, and the management rights dispute has entered a lull. However, with the terms of CEO Baek Jong-hoon and independent director Lee Jung-mi set to expire in March next year, the possibility of another proxy battle between the two sides over the new shareholder return policy and board composition cannot be ruled out.

Gwak Horyung (horr@fntimes.com)

데일리 금융경제뉴스 FNTIMES - 저작권법에 의거 상업적 목적의 무단 전재, 복사, 배포 금지
Copyright ⓒ 한국금융신문 & FNTIMES.com

가장 핫한 경제 소식! 한국금융신문의 ‘추천뉴스’를 받아보세요~

KFT Topic 다른 기사

1 Same Earnings Growth, Opposite Shareholder Returns: APR Up, LG H&H and Amorepacific Down Among major domestic beauty companies, APR was the only one to deliver a "positive return" to shareholders in the first half of this year. While Total Shareholder Return (TSR) at both LG Household & Health Care (LG H&H) and Amorepacific stayed in negative territory, APR posted a TSR of 65.5%.Unlike the traditional cosmetics makers, which struggled to win back market confidence despite improved earnings, APR pulled ahead in the shareholder-value race as steep growth combined with expectations for overseas expansion.According to a disclosure by the Financial Supervisory Service on the 30 2 Kia's Three Growth Engines Fuel Its Historic Charge Toward No. 1 The long-standing formula of South Korea's auto market — Hyundai Motor No. 1, Kia No. 2 — is showing cracks. Kia has narrowed the sales gap with Hyundai Motor to within striking distance, and forecasts that it will claim the top spot in domestic sales for the first time in its history this year are increasingly becoming reality.Kia's sales momentum is attributed to solid performance in its core SUV lineup, combined with the successful rollout of new lineups such as mass-market electric vehicle (EV) models and purpose-built vehicles (PBVs).According to Kia's disclosure on the 28th, the compan 3 SK Biopharmaceuticals Doubles Down: $795M Bet on Second Blockbuster Epilepsy Drug "SK Biopharmaceuticals has now entered a different league, one in which we compete directly with global big pharma companies in the United States and Europe, not just in Korea."President Lee Dong-hoon of SK Biopharmaceuticals made this declaration at a press conference held on the afternoon of the 26th at the Westin Josun Hotel in Jung-gu, Seoul, where he abruptly unveiled the company's license-in (L/I) agreement to acquire opakalim, an epilepsy drug candidate from Ireland-based Biohaven.Through the deal, SK Biopharmaceuticals aims to reduce its reliance on a single product — cenobamate — an
ad
ad
ad

한국금융 포럼 사이버관

더보기

FT카드뉴스

더보기
[그래픽 뉴스] ‘순대’가 경제용어라고? 순(純)대외자산, 한국의 진짜 해외자산은 얼마일까?
[그래픽 뉴스] ISA 대개편! 나에게 유리한 계좌는?
[그래픽 뉴스] 미국 증시 새로운 키워드 'MANGOS'
환전·로또·육아휴직까지 하반기부터 달라지는 제도 TOP11
[그래픽 뉴스] 은퇴후 30년 부모님 세대의 생존전략

FT도서

더보기